. Traditionally, chemical modification of proteins is accomplished by attaching synthetic cargo to nucleophilic amino acid side chains on protein surfaces, such as those associated with lysine or cysteine residues. These methods inherently lack single-site specificity and produce product mixtures with heterogeneity in both the regiochemistry and stoichiometry of the modification. Moreover, the precise location of chemical conjugation can markedly alter protein function and illustrates a need for methods to modify proteins with site specificity 3 . A number of methodologies developed over the last decade address the issue of site-specific protein modification 4 . These techniques primarily focus on introducing orthogonal functionality to amino acid side chains or utilizing enzymes to catalyze selective bond formation. In the former instance, an orthogonal chemical functionality, or 'chemical handle' , can be further elaborated through highly selective covalent reactions. Aldehydes and ketones are examples of such chemical handles, and their addition to proteins has achieved using both genetic 5, 6 and chemical 7 methods. We reported the use of the hexapeptide sequence LCTPSR, derived from the active sites of human type I sulfatases, as a genetically encoded tag for site-specific chemical modification of proteins 6, [8] [9] [10] . This short amino acid sequence (defined by the broader consensus sequence CxPxR) is recognized by the FGE, which catalyzes the co-translational oxidation of the cysteine residue to an aldehydebearing Cα-formylglycine (FGly) residue [11] [12] [13] , a modification that is required for sulfatase activity. Type 1 sulfatases are found in most organisms, and likewise the amino acid modification and FGEs that generate it occur in all domains of life 14 . Notably, FGEs can recognize and modify this short consensus sequence within the context of heterologous proteins 15 . Thus, the sequence can be introduced into recombinant proteins as a means to introduce FGly residues at chosen sites. We exploited this phenomenon for site-specific protein chemical modification as shown in Figure 1 .
The protocol presented here describes two methods for incorporating the aldehyde tag-coding nucleotides into a plasmid-resident gene. We then provide examples of expressing aldehyde-tagged proteins in prokaryotic (E. coli) and eukaryotic (CHO) cell lines and their subsequent site-specific labeling. A method for mass spectrometry (MS)-based analysis of the extent of Cys-to-FGly conversion is also described.
Aldehyde-tagging proteins in an expression vector
We use two methods for introducing aldehyde tag-coding nucleotides into a gene of interest. If there is a convenient restriction site, ligating annealed nucleotides is the preferred method. If no such restriction site exists, we use a site-directed mutagenesis approach.
Prokaryotic expression
Genome mining using human FGE as a query has identified putative FGE orthologs in Mycobacterium tuberculosis and other organisms. Early expression experiments in E. coli, which does not code for an apparent FGE, nonetheless indicated the presence of an FGE-like activity 12 . We found incomplete FGly formation on an
Site-specific chemical protein conjugation using genetically encoded aldehyde tags
We describe a method for modifying proteins site-specifically using a chemoenzymatic bioconjugation approach. Formylglycine generating enzyme (FGe) recognizes a pentapeptide consensus sequence, cxpxr, and it specifically oxidizes the cysteine in this sequence to an unusual aldehyde-bearing formylglyine. 7 . A MS-based assay revealed that C-terminal aldehyde-tagged MBP, when co-expressed with FGE, had a FGly formation efficiency of >85%. This coexpression protocol is now routinely used for the production of aldehyde-tagged proteins in prokaryotes 7, 9 .
Eukaryotic expression
The aldehyde tag technology can be adapted to mammalian expression systems. In eukaryotic cells, endogenous FGE is located in the endoplasmic reticulum lumen, where it normally acts on sulfatases destined for lysosomes or for secretion 16 . This placement allows 3. Dilute cells in 10 ml of growth medium (Ex-Cell 325 PF CHO serum-free medium supplemented with 10% (vol/vol) fetal bovine serum, 1 mM l-glutamine, 100 i.u. penicillin and 100 µg ml − 1 streptomycin), gently pipetting to completely resuspend cells. 4. Transfer cells to a 100-mm tissue culture dish and add 10 ml of growth medium. 5. Incubate cells at 37 °C to a confluence of 90-95%. This step can take 3-4 d. 6. Aspirate the medium and wash with 10 ml of PBS warmed to 37 °C. 7. Decant the PBS and add 12 ml of Opti-MEM I medium warmed to 37 °C. 8. Add 12 µg each of pcDNA3.1-hFGE to 1.5 ml of Opti-MEM I in a 10-ml conical vial. At the same time, in a microcentrifuge tube add 60 µl of Lipofectamine 2000 to 1.5 ml of Opti-MEM I. Incubate each for 5 min at room temperature. 9. Add the diluted Lipofectamine 2000 to the tube of diluted DNA, mix by inverting four times, and then incubate for 20 min at room temperature. 10. Add the mixture of DNA/Lipofectamine 2000 complexes dropwise to the tissue culture dish containing the CHO-K1 cells (the total volume in the dish should be 15 ml). 11. Incubate the cells at 37 °C for 4 h. 12. Aspirate the medium and add 10 ml of growth medium containing 500 µg ml − 1 G418 for 72 h. 13. Repeat Step 12 every 48 h until clonal G418-resistant cell populations are observed (this is generally 10-14 d after transfection). 14. When the cells are ~75% confluent, aspirate the medium and add 2 ml of trypsin-EDTA solution and incubate at 37 °C in the CO 2 incubator for 3 min or until nearly all the cells have lifted off the plate as observed under a microscope. 15. Gently pipette the cells into a conical vial and spin down the cells at 800g for 5 min at 4 °C. 16 . Aspirate the medium and resuspend cells in 10 ml of growth medium containing 500 µg ml − 
Conjugation and analysis of aldehyde-tagged proteins
The aldehyde functionality in a protein can be selectively modified with a diverse array of aminooxy-or hydrazide-functionalized molecules. This includes, but is not limited to, fluorescent imaging probes such as Alexa Fluor 647 C5-aminooxyacetamide, affinity probes such as biotin-hydrazide, aminooxy-functionalized PEG polymers or aminooxy-bearing peptides ( Table 1 and refs. 6-9,10). As a control for labeling experiments, we always generate proteins in parallel with a nonfunctional aldehyde tag, where the crucial cysteine is mutated to alanine (LATPSR). These proteins demonstrate significant labeling with aldehydespecific reagents. Conjugation to FGly using aminooxy-or hydrazide-bearing reagents can be performed in a number of aqueous buffers in slightly acidic pH. The kinetics of the condensation reaction is profoundly affected by the pH and at a pH greater than 6.0, the formation of oximes and hydrazines is considerably slower 17 . Concentration of the reagents is also important. When the protein concentration is below 10 µM, the small-molecule concentration should be above 500 µM in order for the reaction to proceed to completion. At these concentrations, the reactions take 12 h at 37 °C and pH 5.5. Table 1 provides examples of small-molecule payloads and conjugation conditions used to chemically elaborate aldehyde-tagged proteins.
To assess the efficiency of FGly formation, MS can be used. Tryptic digestion of aldehyde-tagged proteins is followed by high-performance liquid chromatography (HPLC)-coupled MS and allows for the direct comparison of FGly-or Cyscontaining fragments with the quantification of the extent of conversion 6 . It is important to note that the formylglycine is hydrated in water to give the geminol diol (Fig. 2) . Both the aldehyde and the diol will be observed as two distinct molecular weights and both chemical species should be factored into the MS analysis.
A schematic illustrating both the ease of modification and the method of chemical modification is shown in Figure 1b . Because the aldehyde tag can be used on target proteins produced in mammalian cells, and thereby it can also make use of endogenous mammalian protein folding and post-translational modification machinery, the ability of native FGE to recognize and modify the aldehyde tag sequence in multiple contexts is noteworthy. Although it is not highlighted in this protocol, incorporation of the aldehyde tag is not limited to the termini of proteins. The aldehyde tag sequence can be incorporated into internal regions of a protein and, if the sequence is solvent accessible, can be conjugated with an aldehyde reactive compound. Furthermore, multiple tags can be inserted into a protein of interest, increasing the amount of chemical payload on an aldehyde-tagged protein of interest. We have, for example, simultaneously inserted three aldehyde tag sequences in human serum albumin and IgG Fc domains (D.R. and G.W.D., unpublished data). Using available structural data, such as X-ray crystallography or NMR spectroscopy, we inserted the FGE recognition sequence in unstructured loop regions located on the protein surface. We did not insert the recognition sequence into structured regions of a protein, such as α-helices and β-sheets, where altering the peptide sequence could impact overall protein structure and function. However, if the site of modification is appropriately selected, we have found that internal aldehyde tag placement and the addition of multiple tags into a protein backbone did not adversely affect protein folding or expression titers. Given the versatility of tag number and position of placement, the utility of the aldehyde tag extends far beyond the applications described herein. For example, the technique could have widespread utility for imaging cellular proteins and chemical modification of therapeutic proteins 3, [18] [19] [20] .
Protocol overview
In this article, protocols are provided for plasmid construction and insertion of the sulfatase motif into two model heterologous proteins. The expression and purification of an aldehyde-tagged protein in E. coli is described, as well as the expression and purification of an aldehyde-tagged protein in mammalian expression systems, specifically in CHO cells. Analysis of the modified proteins by fluorescence is discussed, as is protein analysis and quantification of the conversion of Cys to FGly by MS. For research projects that will require larger amounts of converted protein over longer periods of time, a protocol for generation and propagation of a CHO-K1 cell line stably expressing FGE is provided. 
MaterIals

REAGENTS
REAGENT SETUP Acetic acid, 7.5% (vol/vol) Acetic acid (7.5%, vol/vol) is prepared using DI H 2 3| Incubate the digest reaction at 37 °C for 3 h in a microcentrifuge tube.
 crItIcal step Sticky-ended DNA fragments are required. Do not use blunt cutting restriction endonucleases or nucleases that leave overhangs of less than four bases.
4|
Run digested DNA on a 1% (wt/vol) agarose gel. Cut out the desired band and purify it using a gel extraction kit as instructed by the manufacturer. Elute the purified DNA in 50 µl of elution buffer. This will be used directly in the ligation below.
5|
Separately dissolve the appropriate 5′-phosphorylated oligonucleotides in annealing buffer (refer to table 1).
Oligonucleotides for prokaryote method 1 and 2, at 200 µM Oligonucleotides for eukaryote method 7 and 8, at 200 µM  crItIcal step The oligonucleotides must be phosphorylated at the 5′ ends for the ligation to proceed. The oligonucleotides can be purchased in this form or phosphorylated enzymatically by T4 polynucleotide kinase (NEB, cat. no. M0201).
6| Mix 5 µl of each oligonucleotide solution from either the prokaryote method or the eukaryote method in a PCR tube. Add 1 µl of 5 M NaCl, 1 µl of 100× TE buffer and 89 µl of H 2 O to the oligonucleotide solution.
7| By using a PCR machine, heat the oligonucleotide mixture to 95 °C for 1 min, cool to 85 °C for 1 min, and then cool to 4 °C.  pause poInt The purified digested DNA and the annealed oligonucleotides can be stored at − 20 °C for several weeks.
8|
According to the manufacturer's instructions for T4 DNA ligase, set up 10-µl ligation reactions according to the table below. This is a general method that can be used for both prokaryotes and eukaryotes. ) and incubate for 1 h at 37 °C.
19| Transform 3 µl of the DpnI-treated PCR into chemically competent TOP10 E. coli according to the manufacturer's instructions.
20|
Plate the transformed cells on LB agar plates supplemented with 50 µg ml − 1 kanamycin. Incubate the plates at 37 °C overnight.
21|
Pick several colonies and inoculate 5 ml of LB medium supplemented with 50 µg ml − 1 kanamycin. Grow the cultures overnight.
22|
Mix 750 µl of overnight culture with 750 µl of sterile 50% (vol/vol) glycerol. Store the bacteria glycerol stocks at − 80 °C for future use.
23|
Pellet the remainder of the culture by centrifugation at 4,000g and purify the recombinant plasmid DNA using a plasmid miniprep kit.
24|
Verify the presence of the insert by DNA sequencing.  pause poInt The DNA can be stored at − 20 °C in TE buffer for several years. The frozen glycerol stocks should be stored at − 80 °C. ? troublesHootInG constructing an aldehyde-tagged gene by site-directed mutagenesis • tIMInG 4 d 25| This is done in the same manner as described above (Steps 16-24), with modifications to the PCR components and temperature cycling program as listed below. In addition, the antibiotic used in the LB agar and LB medium is 50 µg ml − 1 carbenicillin. 
33|
The solution is concentrated using Amicon Ultra centrifugal filters to a volume of 20 µl and is exchanged in PBS using a desalting column (PD SpinTrap G-25).
34|
The sample is frozen and stored at − 80 °C.  pause poInt The protein sample can be stored for over 6 months before analysis (described in box 2).
purification of conjugated proteins • tIMInG 3 h 35| Add PBS (pH 7.0) to the reaction mixture from
Step 27 up to a final volume of 400 µl. (Fig. 2) , capped cysteine fragments, and methoxyamine-conjugated fragments to assess percent conversion and conjugation using Masslynx software. antIcIpateD results Figure 3 depicts expected results obtained after Step 27. While staining of the gel with Sypro Orange shows that both LCTPSR-and LATPSR-tagged proteins are present, gel fluorescence measurements show protein conjugation of an aldehyde-specific fluorophore to the LCTPSR-tagged protein, whereas the LATPSR-tagged protein was not converted to a formylglycine and hence not conjugated to the fluorophore. Chemical labeling efficiency is dependent on the pH of the reaction buffer and we have observed substantially decreased conjugation efficiency when the reaction buffer has a pH >6. As a first step in troubleshooting, if no labeling is observed we confirm that the pH of the reaction mixture is as expected. It should be noted that this labeling technique is not effective for proteins that are sensitive to slightly acidic pH.
Labeling efficiency is additionally affected by reagent concentration. If poor labeling is observed, subsequent reactions can be carried out in smaller volumes or with increased concentration of both the aldehyde-tagged protein and the aldehyde-specific small molecule. We have also observed The fluorescence of the gel is measured to determine aldehyde-specific protein conjugation of an aldehyde-specific fluorophore to the LCTPSR-tagged protein; LATPSR-tagged protein is not converted to a formylglycine and will not be conjugated to the fluorophore. Repeat and run the gel longer to elute excess fluorophore Use a desalting spin column to reduce the amount of fluorophore present before SDS-PAGE
